Last reviewed · How we verify
NCT05825469
Development and Testing of Nutritional Algorithms (NACHO)
NA trial testing Nutrition Algorithm in Nutrition Poor in 130 participants. Not yet recruiting.
31 January 2027
Quick facts
| Lead sponsor | Dana-Farber Cancer Institute |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 130 |
| Start date | 1 September 2026 |
| Primary completion | 31 January 2027 |
| Estimated completion | 31 March 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Nutrition Algorithm
Conditions studied
- Nutrition Poor — all drugs for Nutrition Poor →
- Nutritional Deficiency — all drugs for Nutritional Deficiency →
- Quality of Life — all drugs for Quality of Life →
Sponsor
Dana-Farber Cancer Institute
Who can join
18 and older, any sex, with Nutrition Poor or Nutritional Deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this research study is to develop a nutrition algorithm to optimize nutritional status and improve quality of life during for participants who are completing or have completed cancer treatment. The name of the intervention used in this research study is: Nutrition Algorithm for Cancer Health Outcomes (NACHO) (a technology-based platform that houses the algorithms for the person-centered nutrition program)
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05825469
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Nutrition Poor
Currently open trials in the same condition.
- NCT06277232 — Nutrition Care in Patients Living With Chronic Pain · NA · recruiting
- NCT06116422 — Nutrition and Obesity in Under-Represented Populations: Food Insecurity Research to Advance Science and Improve Health · NA · recruiting
- NCT06645639 — Implementation of P-INPAC · recruiting
- NCT05472441 — Linking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK) · NA · recruiting
- NCT05220631 — Digital Nutrition Intervention for Older Adults · NA · active not recruiting
Other Dana-Farber Cancer Institute trials
Trials by the same sponsor.
- NCT07519200 — Sexual Health and Rehabilitation for Women With Metastatic Breast Cancer (SHARE-MC): An Educational Intervention · NA · not yet recruiting
- NCT07499999 — Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk fo · Phase 2 · not yet recruiting
- NCT07516353 — my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults · NA · not yet recruiting
- NCT07513324 — Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0) · Phase 2 · not yet recruiting
- NCT07465276 — Neoadjuvant Ficerafusp Alfa With Pembrolizumab in Resectable SCC · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05825469 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dana-Farber Cancer Institute
- Last refreshed: 6 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05825469.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing